STATE STREET CORP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$802,073
-36.8%
6,432,023
-47.8%
0.00%
Q4 2022$1,269,530
+48.1%
12,325,542
+118.8%
0.00%
Q3 2022$857,000
-75.0%
5,632,066
+44.6%
0.00%
Q2 2022$3,428,000
-23.4%
3,895,398
+7.9%
0.00%
Q1 2022$4,476,000
-73.3%
3,609,840
-58.0%
0.00%
-100.0%
Q4 2021$16,770,000
-22.1%
8,600,234
+9.5%
0.00%0.0%
Q3 2021$21,523,000
+123.3%
7,855,139
+156.7%
0.00%0.0%
Q2 2021$9,638,0003,059,6100.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,736,283$22,886,0009.62%
VR Adviser, LLC 16,047,286$31,292,0004.28%
COMMODORE CAPITAL LP 8,464,999$16,507,0003.82%
Ghost Tree Capital, LLC 2,000,000$3,900,0001.40%
EPIQ PARTNERS, LLC 1,002,350$1,955,0001.04%
HighVista Strategies LLC 577,031$1,125,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 4,024,938$7,849,0000.86%
NEA Management Company, LLC 16,302,596$31,790,0000.64%
Nicholas Investment Partners, LP 4,288,077$8,362,0000.53%
Logos Global Management LP 2,000,000$3,900,0000.40%
View complete list of VISTAGEN THERAPEUTICS INC shareholders